In short
Fibromyalgia is characterised by widespread musculoskeletal pain, fatigue, sleep disruption, cognitive difficulties, and heightened sensitivity to pressure, temperature, and sensory input. At CLCC, care for fibromyalgia follows a five-step structured assessment: Assess, Identify, Reduce, Restore, Continue, addressing the systemic contributors alongside standard medical treatment, rather than symptom management alone.
About This Condition
Fibromyalgia is not pain without cause, it is central sensitisation sustained by a system under load.
Fibromyalgia is characterised by widespread musculoskeletal pain, fatigue, sleep disruption, cognitive difficulties, and heightened sensitivity to pressure, temperature, and sensory input. It is a condition of central sensitisation, the nervous system has become calibrated to amplify pain signals from the entire body, producing pain at a level disproportionate to peripheral tissue damage. Standard investigation returns normal findings because the problem is neurological regulation, not tissue pathology.
Central sensitisation does not arise spontaneously. It is sustained by a systemic load that keeps the nervous system in a state of amplified sensitivity. Mitochondrial dysfunction reduces neuronal energy availability, impairing the nervous system's capacity to self-regulate. Gut dysbiosis reduces serotonin production and elevates inflammatory markers that maintain central sensitisation. Vitamin D, magnesium, and B12 deficiencies directly impair neurological function. Chronic stress load maintains HPA axis activation that sustains the sensitised state. Disrupted sleep, the primary period of nervous system recovery, prevents the downregulation that would otherwise reduce central sensitisation. CLCC addresses all of these simultaneously.
Symptoms
Common symptoms and presentations.
Widespread pain across multiple body regions, both sides of the body, above and below the waist
Fatigue that is not proportionate to activity level and is not relieved by rest
Non-restorative sleep, waking exhausted despite adequate hours in bed
Cognitive difficulties, 'fibro fog', poor concentration, word-finding difficulty, memory problems
Heightened sensitivity to touch, pressure, temperature, and light
Morning stiffness that improves but does not fully resolve with activity
Irritable bowel symptoms co-occurring with widespread pain
Headaches, often tension-type or migraine, as a frequent co-condition
Anxiety and depression, both cause and consequence of the fibromyalgia pain cycle
Symptoms that worsen predictably with stress, poor sleep, or physical overexertion
Contributing Factors
What drives and sustains this condition.
Mitochondrial dysfunction
Fibromyalgia patients show impaired mitochondrial energy production in muscle tissue and neuronal cells, reducing the energy available for pain signal regulation and fatigue recovery. Mitochondrial support through CoQ10, ALC, and riboflavin addresses this directly.
Gut dysbiosis and reduced serotonin production
95% of the body's serotonin is produced in the gut. Gut dysbiosis reduces serotonin availability, impairing the descending pain inhibitory pathways that normally limit pain signal amplification. Gut restoration is a fibromyalgia intervention.
Nutritional deficiencies
Magnesium deficiency sustains muscle tension and lowers pain thresholds. Vitamin D deficiency is associated with widespread musculoskeletal pain and is found at elevated rates in fibromyalgia patients. B12 deficiency impairs nerve function and myelination.
Neuro-stress load and HPA axis dysregulation
Chronic stress maintains the HPA axis in an activated state, sustaining the neuroinflammatory environment that keeps central sensitisation elevated. The stress-fibromyalgia cycle is self-perpetuating without systematic stress-load reduction.
The CLCC Method: All Five Steps
Assessment first. Then all five steps, applied specifically.
Full assessment: mitochondrial markers, gut health, nutritional status, sleep, and stress load
CoQ10, ALC, magnesium, vitamin D, B12 assessed. Gut microbiome indicators evaluated. Sleep quality and architecture reviewed. Stress load and HPA axis indicators assessed. Physical function and pain pattern scored at baseline.
Identify dominant contributors, mitochondrial, gut, nutritional, or neuro-stress
Different dominant patterns require different primary intervention emphasis. Mitochondrial-dominant fibromyalgia responds primarily to CoQ10, ALC, and riboflavin. Gut-dominant responds to microbiome restoration. Stress-dominant requires HPA axis correction as the priority.
Coordinated mitochondrial support, gut restoration, nutritional correction, and stress-load reduction
Therapeutic CoQ10 and ALC for mitochondrial support. Gut barrier repair and microbiome restoration. Magnesium, vitamin D, and B12 correction. Anti-inflammatory dietary protocol. Sleep hygiene correction. Structured stress-load reduction, all simultaneously.
Track pain score, fatigue level, and sleep quality at monthly intervals
Validated fibromyalgia impact questionnaire and pain scoring reviewed monthly. Sleep quality and cognitive function assessed. Nutritional marker levels rechecked at 3-month intervals. Protocol refined based on measured response.
Sustain central sensitisation reduction through long-term systemic maintenance
Central sensitisation returns when the systemic load that produced it reaccumulates. The Continue phase monitors nutritional status, gut health, and stress indicators, maintaining the systemic environment that allows the nervous system to remain desensitised.
FAQs
Common questions about care.
Is fibromyalgia a real condition?+
Yes. Fibromyalgia is a well-documented neurological condition characterised by central sensitisation, measurable abnormalities in pain processing that are demonstrable through neuroimaging and neurophysiological studies. The absence of peripheral tissue pathology on standard investigation reflects the central nature of the condition, not the absence of a condition.
Why does exercise make fibromyalgia worse?+
Post-exertional worsening in fibromyalgia occurs because mitochondrial dysfunction impairs the energy recovery process after physical exertion. The nervous system and muscle tissue cannot recover from physical loading at the normal rate. CLCC's approach addresses mitochondrial function first, enabling a return to graduated physical activity without post-exertional relapse.